By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


Drug Discovery

Company News
PTC Therapeutics (PTCT) Appoints Dr. Tuyen Ong As Chief Medical Officer 4/27/2016 6:11:32 AM
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/25/2016 6:06:50 AM
PTC Therapeutics (PTCT) To Host Conference Call To Discuss First Quarter Financial Results 4/22/2016 6:32:10 AM
PTC Therapeutics (PTCT) Release: National Institute for Clinical Excellence (NICE) Recommends Translarna (Ataluren) For The Treatment Of Patients With Nonsense Mutation Duchenne Muscular Dystrophy In England 4/15/2016 10:07:46 AM
Top 5 Biotech Winners and Losers of Q1 2016 3/31/2016 7:08:32 AM
PTC Therapeutics (PTCT) Chops 18% of Workforce 3/23/2016 2:51:12 PM
PTC Therapeutics (PTCT) Provides Update On Health Canada Review Of Translarna (ataluren) For The Treatment Of Duchenne Muscular Dystrophy 3/14/2016 6:34:37 AM
PTC Therapeutics (PTCT) Selects Lecorpio’s Secure, Hosted Environment To Manage Patent Prosecution And Annuity Payments 3/8/2016 10:19:50 AM
PTC Therapeutics (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/2/2016 6:14:10 AM
PTC Therapeutics (PTCT) Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Corporate Update 3/1/2016 8:25:25 AM